New options for drug treatment of obesity in patients with Type 2 diabetes

被引：1
|
作者：
Kennedy, RL [1 ]
Khoo, EYH
机构：
[1] James Cook Univ N Queensland, Dept Med, Townsville, Qld 4811, Australia
[2] Queens Med Ctr, Dept Endocrinol & Diabet, Nottingham NG7 2UH, England
来源：
DIABETIC MEDICINE | 2005年 / 22卷
关键词：
D O I：
10.1111/j.1464-5491.2005.1761h.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：23 / 26
页数：4
相关论文
共 50 条
  • [1] New options for the treatment of obesity and type 2 diabetes mellitus (narrative review)
    Henry, Robert R.
    Chilton, Robert
    Garvey, W. Timothy
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2013, 27 (05) : 508 - 518
  • [2] Lifestyle Modifications and Surgical Options in the Treatment of Patients with Obesity and Type 2 Diabetes Mellitus
    Ritter, Scott
    Vetter, Marion L.
    Sarwer, David B.
    POSTGRADUATE MEDICINE, 2012, 124 (04) : 168 - 180
  • [3] Drug evaluation: Tagatose in the treatment of type 2 diabetes and obesity
    Moore, Mary Courtney
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (10) : 924 - 935
  • [4] Expanding Treatment Options for Type 2 Diabetes The Old and the New
    Pratley, Richard E.
    DIABETES EDUCATOR, 2009, 35 : 4S - 11S
  • [5] Treatment of Type 2 Diabetes in Patients with Obesity A Review
    Guzman, Heidi
    Hasan, Leen Z.
    Reid, Tirissa J.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2025, 54 (01) : 163 - 173
  • [6] Imeglimin: a new antidiabetic drug with potential for the treatment of patients with type 2 diabetes
    Nowak, Mariusz
    Grzeszczak, Wladyslaw
    ENDOKRYNOLOGIA POLSKA, 2022, 73 (02) : 361 - 370
  • [7] Saxagliptin: A New Drug for the Treatment of Type 2 Diabetes
    Thareja, Suresh
    Aggarwal, Saurabh
    Malla, Priyanka
    Haksar, Diksha
    Bhardwaj, Tilak Raj
    Kumar, Manoj
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (08) : 759 - 765
  • [8] Azoramide: a new drug for the treatment of type 2 diabetes?
    Guillen, Carlos
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4
  • [9] Optimizing drug treatment for patients with type 2 diabetes
    Letonturier, Philippe
    PRESSE MEDICALE, 2007, 36 (05): : 813 - 815
  • [10] NAFLD/NASH in patients with type 2 diabetes and related treatment options
    Radaelli, M. G.
    Martucci, F.
    Perra, S.
    Accornero, S.
    Castoldi, G.
    Lattuada, G.
    Manzoni, G.
    Perseghin, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2018, 41 (05): : 509 - 521
12345